NCT00003346View on ClinicalTrials.gov

Combination Chemotherapy in Treating Patients With Stage III or Stage IV Melanoma

PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

November 30, 1997

Primary Completion Date

February 28, 2003

Study Completion Date

February 28, 2003

Conditions
Melanoma (Skin)
Interventions
DRUG

acetaminophen

DRUG

acetylcysteine

DRUG

carmustine

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00003346 - Combination Chemotherapy in Treating Patients With Stage III or Stage IV Melanoma | Biotech Hunter | Biotech Hunter